Mirvie Inc
820 Dubuque Avenue
South San Francisco
CA
94080
United States
Website: https://mirvie.com/
Email: careers@mirvie.com
8 articles about Mirvie Inc
-
Mirvie Becomes First RNA-Based Pregnancy Health-Focused Company to Receive Clinical Laboratory Improvement Amendments (CLIA) Certification
9/26/2023
Mirvie has been certified by the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity clinical testing.
-
Mirvie Receives $4.6 Million Grant to Study Objective Prediction of Preeclampsia in Sub-Saharan Africa
8/2/2023
Mirvie announced a $4.6 million grant from the Bill & Melinda Gates Foundation to support the company’s efforts to predict unexpected pregnancy complications before they happen by revealing the underlying biology of each pregnancy for women on a global scale.
-
First Comprehensive Care Plan to Prevent Preeclampsia Published in the American Journal of Obstetrics and Gynecology
4/28/2023
A new special report published in the American Journal of Obstetrics and Gynecology provides a groundbreaking approach to preeclampsia, one of the most pressing issues in maternal health and will translate the prediction of risk into prevention of disease.
-
Mirvie Expands Leadership Team with Appointment of Alison Cowan, M.D. as Head of Medical Affairs
8/30/2022
Mirvie, a pioneer in predicting unexpected pregnancy complications, announced the appointment of Alison Cowan, M.D., M.S.C.R. as Head of Medical Affairs.
-
Recent funding saw support for a platform that selectively degrades DNA, software to help read mammograms and a company using corn genetics to develop cancer-targeting viruses.
-
Mirvie Raises $60 Million Funding Round to Shape the Future of Pregnancy Health
5/17/2022
Mirvie, a pioneer in predicting unexpected pregnancy complications, announced it has raised a total of $90 million to date following the close of its Series B funding.
-
Late-breaking Data Presented at SMFM 2022 Annual Meeting Shows The Mirvie RNA Platform is First to Reveal The Underlying Biology of Preterm Birth
2/4/2022
Mirvie, a pioneer in predicting unexpected pregnancy complications, announced data presented at the Society for Maternal-Fetal Medicine 42nd Annual Pregnancy Meeting demonstrates the Mirvie RNA platform is first to predict preterm birth by revealing the underlying biology of each pregnancy.
-
Study Published in Nature Shows Mirvie Can Predict Pregnancy Complications Months Before They Happen Using New, Proprietary RNA Platform
1/5/2022
Mirvie, a pioneer in predicting unexpected pregnancy complications, today announced the publication of a study in Nature proving the proprietary Mirvie RNA platform is first to predict unexpected complications by revealing the underlying biology of each pregnancy.